CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 71 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,000 | -41.7% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $12,000 | +50.0% | 3,000 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $8,000 | 0.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | +33.3% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | +100.0% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $3,000 | 0.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -50.0% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -42.9% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $7,000 | -22.2% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $9,000 | -25.0% | 3,000 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $12,000 | -53.8% | 3,000 | -50.0% | 0.01% | 0.0% |
| Q1 2015 | $26,000 | +188.9% | 6,000 | +100.0% | 0.01% | +40.0% |
| Q4 2014 | $9,000 | -10.0% | 3,000 | 0.0% | 0.01% | -16.7% |
| Q3 2014 | $10,000 | +25.0% | 3,000 | 0.0% | 0.01% | +20.0% |
| Q2 2014 | $8,000 | +14.3% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $7,000 | +16.7% | 3,000 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $6,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |